Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Osmotica Pharmaceuticals Q3 EPS $(0.42) Misses $(0.36) Estimate, Sales $2.20M Miss $2.35M Estimate

Author: Bill Haddad | November 15, 2021 06:33pm
Osmotica Pharmaceuticals (NASDAQ:OSMT) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.36) by 16.67 percent. This is a 200 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $2.20 million which missed the analyst consensus estimate of $2.35 million by 6.55 percent. This is a 96.16 percent decrease over sales of $57.17 million the same period last year.

Posted In: OSMT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist